101 % Year-Over-Year Increase in First Quarter Revenues to $ 5 . 9 M illion; 1 41 % SaaS Revenue Growth ; Record $8 . 0 Million in New SaaS Bookings Atlanta, GA , June 08, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading
First quarter fiscal 2023 SaaS revenue up 12% compared to first quarter fiscal 2022 $17.8 million of Booked SaaS ACV as of April 30, 2023 compared to $17.2 million as of January 31, 2023 ; $12.7 million of Booked SaaS ACV implemented as of April 30, 2023 Atlanta, GA , June 12, 2023 (GLOBE NEWSWIRE)
Fourth Quarter Revenues of $ 6.0 M illion; 1 55 % SaaS Revenue Growth ; $30,000 in Net Loss; ( $ 0.3) M illion in Adjusted EBITDA Atlanta, GA , April 27, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“ Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of
Fiscal 2022 SaaS revenue up 53% vs fiscal 2021 Total contract value of fiscal 2022 SaaS bookings was $22.4 million compared to $5.6 million in fiscal 2021 Reported $17.2 million of Booked SaaS ACV as of January 31, 2023 , compared to $10.6 million as of January 31, 2022 Executed strategic alignment
14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022 $0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ( $0.2 million ) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs.
10 9 % Year-Over-Year Increase in Second Quarter Revenues to $ 6.0 M illion; 138 % SaaS Revenue Growth ; $ 4.4 Million in New SaaS Bookings Atlanta, GA , Sept. 07, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of
1 3 % growth of SaaS revenue in the first half of fiscal 2023 compared to the first half of fiscal 2022 Atlanta, GA , Sept. 13, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM) , a leading provider of solutions that enable healthcare
Revenues of $ 5.5 M illion; 214 % SaaS Revenue Growth ; $(4.3) Million Net Loss; $(0.3) M illion Adjusted EBITDA Atlanta, GA , Dec. 08, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“ Streamline” or the “Company”) (Nasdaq: STRM), provider of the eValuator ™ Revenue
Total contract value of SaaS bookings for the nine months ended October 31, 2022 was $14.1 million compared to $3.9 million during the same period of fiscal 2021 Strengthened balance sheet with recent capital raise of $8.3 million Third quarter 2022 SaaS revenue up 14% vs.
22% growth of SaaS revenue in the third quarter of fiscal 2023 compared to the third quarter of fiscal 2022 $400 thousand of Adjusted EBITDA generated in the third quarter of fiscal 2023 compared to ($1.2) million during the third quarter of fiscal 2022 $13.0 million of Booked SaaS ACV as of